The Independent Payment Advisory Board (IPAB) was created under the Affordable Care Act (ACA) as a way to control Medicare spending. The Board consisting of 16 bureaucrats appointed by the President, was given the sole authority to make cost-cutting decisions with almost no oversight and no means for challenging its decisions. Also, changes made by IPAB cannot be overruled by the Administration or courts.
MichBio strongly supports full repeal of the IPAB. Leaving reimbursement decisions solely in the hands of one insular, autocratic body that limits stakeholder participation and input will have a negative impact on patient access to quality care. Moreover, there is no guarantee that IPAB's recommendations will reduce healthcare expenses, and could in fact increase costs outside Medicare.